This work shows that the endogenous expression of an oncogenic version of the RHO exchange factor VAV1 (VAV1Onc) promotes TFH cell hyperplasia and, upon loss of TP53, the generation of angioimmunoblastic T cell lymphoma. This evidence concerns the gene TP53 and angioimmunoblastic T-cell lymphoma.